Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-08-24 Tax Withholding | 2025-08-26 8:05 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | 7,488 | $0.5863 | 2,183,972 (Direct) | View |
| 2025-08-24 Tax Withholding | 2025-08-26 8:03 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology | 723 | $0.5863 | 201,222 (Direct) | View |
| 2025-08-24 Tax Withholding | 2025-08-26 8:01 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, CHIEF LEGAL OFFICER, SECY | 1,434 | $0.5863 | 748,243 (Direct) | View |
| 2025-08-24 Tax Withholding | 2025-08-26 8:00 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | 1,792 | $0.5863 | 744,487 (Direct) | View |
| 2025-08-24 Tax Withholding | 2025-08-26 7:59 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | 1,792 | $0.5863 | 766,089 (Direct) | View |
| 2025-07-22 Tax Withholding | 2025-07-24 4:59 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | 31,866 | $0.4798 | 746,279 (Direct) | View |
| 2025-07-22 Tax Withholding | 2025-07-24 4:58 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | 126,950 | $0.4798 | 2,191,460 (Direct) | View |
| 2025-07-22 Tax Withholding | 2025-07-24 4:57 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, CHIEF LEGAL OFFICER, SECY | 31,866 | $0.4798 | 749,677 (Direct) | View |
| 2025-07-22 Tax Withholding | 2025-07-24 4:56 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | 31,866 | $0.4798 | 767,881 (Direct) | View |
| 2025-07-22 Tax Withholding | 2025-07-24 4:55 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology | 6,708 | $0.4798 | 201,945 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:05 pm | N/A 2035-06-11 | SANGAMO THERAPEUTICS INC | SGMO | Smith Karen L. Director | 75,000 | $0 | 152,100 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:05 pm | N/A 2035-06-11 | SANGAMO THERAPEUTICS INC | SGMO | PARKER H STEWART Director | 75,000 | $0 | 162,600 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:05 pm | N/A 2035-06-11 | SANGAMO THERAPEUTICS INC | SGMO | Meyers James R Director | 75,000 | $0 | 149,600 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:05 pm | N/A 2035-06-11 | SANGAMO THERAPEUTICS INC | SGMO | Hillan Kenneth J. Director | 75,000 | $0 | 149,600 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:05 pm | N/A 2035-06-11 | SANGAMO THERAPEUTICS INC | SGMO | Markels John Director | 75,000 | $0 | 146,384 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:05 pm | N/A 2035-06-11 | SANGAMO THERAPEUTICS INC | SGMO | Carey Robert Director | 75,000 | $0 | 149,600 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:05 pm | N/A 2035-06-11 | SANGAMO THERAPEUTICS INC | SGMO | Horn Margaret A Director | 75,000 | $0 | 132,650 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:05 pm | N/A 2035-06-11 | SANGAMO THERAPEUTICS INC | SGMO | Beers Courtney Director | 75,000 | $0 | 132,650 (Direct) | View |
| 2025-05-24 Tax Withholding | 2025-05-28 4:05 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology | 723 | $0.4733 | 208,653 (Direct) | View |
| 2025-05-24 Tax Withholding | 2025-05-28 4:05 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, CHIEF LEGAL OFFICER, SECY | 1,433 | $0.4733 | 781,543 (Direct) | View |
| 2025-05-24 Tax Withholding | 2025-05-28 4:05 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | 1,792 | $0.4733 | 799,747 (Direct) | View |
| 2025-05-24 Tax Withholding | 2025-05-28 4:05 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | 1,792 | $0.4733 | 778,145 (Direct) | View |
| 2025-05-24 Tax Withholding | 2025-05-28 4:05 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | 7,488 | $0.4733 | 2,318,410 (Direct) | View |
| 2025-04-22 Tax Withholding | 2025-04-24 4:10 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | 31,866 | $0.7763 | 782,976 (Direct) | View |
| 2025-04-22 Tax Withholding | 2025-04-24 4:09 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | 31,866 | $0.7763 | 779,937 (Direct) | View |
| 2025-04-22 Tax Withholding | 2025-04-24 4:08 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | 126,950 | $0.7763 | 2,325,898 (Direct) | View |
| 2025-04-22 Tax Withholding | 2025-04-24 4:07 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | 31,866 | $0.7763 | 801,539 (Direct) | View |
| 2025-04-22 Tax Withholding | 2025-04-24 4:05 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology | 6,708 | $0.7763 | 209,376 (Direct) | View |
| 2025-02-25 Tax Withholding | 2025-02-26 5:33 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology | 507 | $0.9561 | 315,538 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 5:33 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology | 705 | $1 | 315,538 (Direct) | View |
| 2025-02-25 Option Award | 2025-02-26 5:33 pm | N/A 2035-02-24 | SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology | 149,180 | $0 | 315,538 (Direct) | View |
| 2025-02-25 Tax Withholding | 2025-02-26 5:32 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | 1,513 | $0.9561 | 1,393,405 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 5:32 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | 1,792 | $1 | 1,393,405 (Direct) | View |
| 2025-02-25 Option Award | 2025-02-26 5:32 pm | N/A 2035-02-24 | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | 680,000 | $0 | 1,393,405 (Direct) | View |
| 2025-02-25 Tax Withholding | 2025-02-26 5:32 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | 1,375 | $0.9561 | 1,374,842 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 5:32 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | 1,434 | $1 | 1,374,842 (Direct) | View |
| 2025-02-25 Option Award | 2025-02-26 5:32 pm | N/A 2035-02-24 | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | 680,000 | $0 | 1,374,842 (Direct) | View |
| 2025-02-25 Tax Withholding | 2025-02-26 5:31 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | 1,375 | $0.9561 | 1,371,803 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 5:31 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | 1,792 | $1 | 1,371,803 (Direct) | View |
| 2025-02-25 Option Award | 2025-02-26 5:31 pm | N/A 2035-02-24 | SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | 680,000 | $0 | 1,371,803 (Direct) | View |
| 2025-02-25 Tax Withholding | 2025-02-26 5:30 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | 10,663 | $0.9561 | 4,202,848 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 5:30 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | 7,488 | $1 | 4,202,848 (Direct) | View |
| 2025-02-25 Option Award | 2025-02-26 5:30 pm | N/A 2035-02-24 | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | 2,125,000 | $0 | 4,202,848 (Direct) | View |
| 2025-01-22 Tax Withholding | 2025-01-24 4:05 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology | 30,456 | $1.15 | 167,570 (Direct) | View |
| 2025-01-22 Tax Withholding | 2025-01-24 4:05 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | 129,593 | $1.15 | 716,710 (Direct) | View |
| 2025-01-22 Tax Withholding | 2025-01-24 4:05 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | 129,549 | $1.15 | 697,651 (Direct) | View |
| 2025-01-22 Tax Withholding | 2025-01-24 4:05 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | 129,242 | $1.15 | 694,970 (Direct) | View |
| 2025-01-22 Tax Withholding | 2025-01-24 4:05 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | 412,584 | $1.15 | 2,095,999 (Direct) | View |
| 2024-11-25 Tax Withholding | 2024-11-26 4:10 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology | 505 | $1.94 | 201,863 (Direct) | View |
| 2024-11-24 Tax Withholding | 2024-11-26 4:10 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology | 721 | $1.88 | 201,863 (Direct) | View |
| 2024-11-25 Tax Withholding | 2024-11-26 4:09 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | 1,371 | $1.94 | 827,200 (Direct) | View |
| 2024-11-24 Tax Withholding | 2024-11-26 4:09 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | 1,430 | $1.88 | 827,200 (Direct) | View |